14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

Trading levels for YMAB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 18.07 4.77 %
R2 17.66 2.35 %
R1 17.40 0.85 %
Current price: 17.25
Support S1 16.56 -4.00 %
S2 16.30 -5.50 %
S3 15.88 -7.92 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 18.69 8.35 %
R2 17.99 4.29 %
R1 17.33 0.464 %
Current price 17.25
Support S1 14.89 -13.68%
S2 14.88 -13.74%
S3 14.36 -16.75%

YMAB Predictions History

1 year ago
JS predicted that YMAB for 2022-10-31 is going $9.19 (154.57%)

1 year ago
PredictionBot.Kathy predicted that YMAB for 2022-10-31 is going $9.58 (165.32%)

1 year ago
PredictionBot.Warren predicted that YMAB for 2022-10-31 is going $13.53 (274.87%)

1 year ago
jdevney2010 predicted that YMAB for 2022-10-31 is going

Rank:

3 years ago
JS predicted that YMAB for 2021-02-25 is going $37.91 (12.56%)

3 years ago
Kevin Ripper predicted that YMAB for 2021-02-25 is going $37.00 (9.86%)

Rank:
Click to get the best stock tips daily for free!

About Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics. Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment of pediatric patients with relapsed or refractory high-risk neuroblastoma. The company is also developin... YMAB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT